CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2024	Mar. 31, 2024
Current assets:
Cash and cash equivalents	$ 151,658	$ 74,457
Short-term investments	317,466	346,211
Research and development incentives receivable	4,933	4,922
Prepaid expenses and other current assets	6,263	8,077
Total current assets	480,320	433,667
Property, plant and equipment, net	11,403	10,483
Research and development incentives receivable, non-current	438	0
Restricted cash	1,700	1,700
Right-to-use asset - operating leases	4,475	4,635
Right-to-use asset - financing leases	36,629	37,237
Total assets	534,965	487,722
Current liabilities:
Accounts payable	864	2,578
Accrued expenses and other current liabilities	30,914	33,981
Operating lease liabilities, current	1,164	1,161
Financing lease liabilities, current	2,738	2,718
Total current liabilities	35,680	40,438
Operating lease liabilities, non-current	3,600	3,771
Financing lease liabilities, non-current	23,256	23,410
Long term debt, net of discount	45,192	44,809
Other liabilities, non-current	786	786
Total liabilities	108,514	113,214
Commitments and contingencies (Note 14)
Stockholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized as of June 30, 2024 and March 31, 2024; 68,309,968 and 61,415,105 shares issued and outstanding as of June 30, 2024 and March 31, 2024, respectively	68	61
Additional paid-in capital	1,177,113	1,070,874
Accumulated deficit	(755,054)	(701,282)
Accumulated other comprehensive income	4,324	4,855
Total stockholders' equity	426,451	374,508
Total liabilities and stockholders' equity	$ 534,965	$ 487,722